Increased incidence of breast, ovarian and endometrial cancers are observed in women receiving estrogen replacement therapy (ERT). Equilin and equilenin are the major components of the widely prescribed drug used for ERT. These equine estrogens are metabolized primarily to 4-hydroxyequilin (4-OHEQ) and 4-hydroxyequilenin, respectively, which are autoxidized to react with DNA, resulting in the various DNA damages. To explore the mutagenic potential of equine estrogen metabolites, a double-stranded pMY189 shuttle vector carrying a bacteria suppressor tRNA gene, supF, was exposed to 4-OHEQ and transfected into human fibroblast. Plasmids containing mutations in the supF gene were detected with indicator bacteria and mutated colonies obtained were analyzed by automatic DNA sequencing. The proportion of plasmids with the mutated supF gene was increased dose-dependently. The majority of the 4-OHEQ-induced mutations were base substitutions (78%); another 22% were deletions and insertions. Among the base substitutions, 56% were single base substitutions and 19% were multiple base substitutions. The majority (86%) of the 4-OHEQ-induced single base substitutions occurred at
Introduction
Estrogen replacement therapy (ERT) is most widely used among postmenopausal women to decrease menopausal symptoms and also to protect against osteoporosis (1) . More than 40% of US women in this group currently receive ERT. Premarin (Wyeth-Ayerst), composing of~50% estrogen, 30% equilin, 10% equilenin and 10% 8,9-dehydroestrogen, is used for this purpose (reviewed in ref. 2) . However, ERT showed a significant increase in the risk of developing breast (3, 4) , ovarian (5) and endometrial cancers (6) . Significant elevation of cancer risks was associated with increasing duration of ERT (5, 7) . The occurrence of endometrial hyperplasia was observed in postmenopausal women receiving ERT (8) . Treatment of hamsters for 9 months with estrone, equilin or equilenin resulted in 100% tumor incidence and many tumor foci in kidneys (9) . DNA adducts have also been detected in the tissues of rodents treated with natural and synthetic estrogens (10) . Major metabolites of equine estrogens react readily with the DNA in vitro, resulting in the formation of large number of DNA adducts (2, 11) . Therefore, exogenous estrogens may be involved in the initiation of breast, ovarian and endometrial cancers.
Like estrogen, equilin and equilenin are metabolized to 4-hydroxyl and 2-hydroxyl forms (2) . However, there is no information regarding the level of equine estrogens and their fate in tissues of women treated with Premarin although pharmacokinetics of Premarin has been reported (12, 13) . 4-Hydroxyequilenin (4-OHEN) is rapidly autoxidized to an o-quinone which in turn readily reacts with DNA, resulting in the formation of unique dC, dA and dG adducts ( Figures 1  and 2) ; the dA adduct is unstable, generating apurinic sites (14) . Using 32 P-post-labeling/polyacrylamide gel electrophoresis (PAGE) analysis (15), we have observed that 4-OHEN are highly reactive with DNA; large amounts of 4-OHEN±dC adduct, accompanied by lesser amounts of 4-OHEN±dA adduct, are detected. 4-Hydroxyequilin (4-OHEQ) is also autoxidized to an o-quinone, which isomerizes to 4-OHEN o-quinone ( Figure 1) ; therefore, 4-OHEQ produces identical DNA adducts that are observed with 4-OHEN (16) . During redox cycling between 4-OHEN o-quinone and their semi-quinone radicals, it generates superoxide, hydrogen peroxide and ultimately reactive hydroxyl radicals (17) . When 4-OHEN was incubated with DNA in vitro or exposed to cultured breast cancer cells, increased formation of 8-oxo-7,8-dihydro-2 Hdeoxyguanosine (8-oxodG) and 8-oxo-7,8-dihydro-2 H -deoxyadenosine (8-oxo-dA) adducts was observed in the DNA (17± 21). Particularly, when 4-OHEN was injected directly into the mammary fat pads of rats, 4-OHEN±dA and 4-OHEN±dG adducts, in addition to increased formation of 8-oxodG, were detected in the mammary tissue using LC/MS/MS spectroscopy (22) . If equine estrogen±DNA adducts are mutagenic, such DNA adducts may have association in initiating cancers.
In the present study, pMY189 shuttle vector plasmids were exposed to 4-OHEQ and transfected into human fibroblast. The mutational frequency and spectrum occurred in the supF gene of the plasmids were analyzed. We found that 4-OHEQ, an equine estrogen metabolite, was mutagenic.
Materials and methods

Materials
Ampicillin, chloramphenicol, nalidixic acid, isopropyl-b-D-thiogalactoside (IPTG) and 5-bromo-4-chloro-3-indoyl-b-D-galactoside (X-gal) were obtained from Nakalai Tesque (Kyoto, Japan). Calf thymus DNA, micrococcal nuclease and potato apyrase were purchased from Sigma-Aldrich (St Louis, MO in this study. The cells were cultured in Dulbecco's modified minimum essential medium (Nikken, Kyoto, Japan) supplemented with 10% fetal bovine serum (Hyclone, Logan, UT) at 37 C in a CO 2 incubator.
Shuttle vector plasmid and bacterial strains
The shuttle vector plasmid pMY189, constructed previously by Matsuda et al. (24) , was used for analysis of mutations induced by 4-OHEQ. The pMY189 was derived from the pZ189 (25) as described previously (24) . The indicator Escherichia coli strain KS40/pKY241 (26) , which is a nalidixic acid-resistant (gyrA) derivative of MBM7070 [lacZ(am) CA7070 lacY1 HsdR HsdM D (araABC-leu) 7679 galU galK rpsL thi] (27), was used for detection of the mutated pMY189. The plasmid pKY241 was constructed by Akasaka et al. (26) and contained a chloramphenicol resistant marker and a gyrA (amber) gene.
Transfection of pMY189 modified with 4-OHEQ to human cells 4-OHEQ was prepared using an established protocol (28) . A purified stock of pMY189 was prepared with the QIAGEN Plasmid Purification Kit. The plasmid pMY189 (20 mg) was reacted at 37 C for 1 h with variable amounts of 4-OHEQ (0.02±2.0 mg in 10 ml DMSO) in 1.0 ml of 25 mM potassium phosphate buffer (pH 7.4). After the reaction, the plasmid DNA was recovered by ethanol precipitation, evaporated to dryness and then dissolved in TE buffer (pH 8). The human WI38-VA13 cells (2 Â 10 7 ) were transfected with 4-OHEQ-treated pMY189 (2 mg) with LIPOFECTAMINE TM Reagent and incubated at 37
C for 72 h in a CO 2 incubator. Then, the plasmid was extracted from the cells using QIAprep-spin Plasmid kit and digested with the restriction endonuclease DpnI to eliminate non-replicated input plasmids with the bacterial methylation pattern.
Analysis of mutated supF gene
Plasmid DNA was introduced into the indicator bacteria E.coli KS40/pKY241 by the electroporation apparatus E.coli Pulser (Bio-Rad Laboratories, Hercules, CA). The bacteria were spread on LB agar plates containing 50 mg/ml of nalidixic acid, 150 mg/ml of ampicillin and 30 mg/ml of chloramphenicol, together with IPTG and X-gal. Plasmids with mutated supF genes made E.coli cells resistant to nalidixic acid, whereas cells carrying plasmids with unmutated supF genes could not grow in the presence of nalidixic acid. IPTG and X-gal were added to confirm selection of the mutated supF gene by the color of the colonies. A portion of the bacteria was spread on plates containing ampicillin and chloramphenicol to measure the transformant fraction and plasmid survival. Mutated plasmids were extracted and purified from the overnight culture. The sequences of the supF gene of the plasmids were determined with the À21M13 primer and Dye-Primer Cycle Sequencing reagent kit using a 370A automatic DNA sequencer (Applied Biosystems Foster, CA).
Determination of 4-OHEQ-derived DNA adducts in pMY189 plasmid Plasmid DNA sample (0.1 mg) was enzymatically digested at 37 C for 2 h in 30 ml of 17 mM sodium succinate buffer (pH 6.0) containing 8 mM CaCl 2 , using micrococcal nuclease (15 U) and spleen phosphodiesterase (0.05 U). The reaction mixture was incubated for another 1 h with nuclease P1 (1.0 U). The DNA digests were incubated at 37 C for 40 min with [g-32 P]ATP (20 mCi) and 3 H -phosphatase free T4 polynucleotide kinase (20 U) in 20 ml of 500 mM Tris± HCl buffer (pH 7.5) containing 100 mM MgCl 2 , 100 mM DTT and 10 mM spermidine, and then incubated with 50 mU of apyrase for another 30 min. 4-OHEQ (2 mg in 10 ml DMSO) was also reacted at 37 C for 5 h with dN 3 H P (0.5 mg) in 1.0 ml of 25 mM potassium phosphate buffer, pH 7.4. After the centrifugation, one-twentieth of the supernatant was evaporated to dryness and incubated at 37 C for 1 h with nuclease P1 (1.0 U) in 20 ml of 17 mM sodium succinate buffer (pH 6.0) containing 8 mM CaCl 2 . The reaction mixture was evaporated to dryness and labeled with 32 P, as described for the 4-OHEQmodified DNA samples. A part of the 32 P-labeled samples was analyzed by 32 P-post-labeling/PAGE (15). 4-OHEN was synthesized using an established protocol (14) and reacted with dC 3 H P and dA 3 H P , as described for 4-OHEQ. 4-OHEN±dC 3 H P and 4-OHEN±dA 3 H P were isolated by HPLC (29) and their molecular weight was confirmed using FAB mass spectroscopy. 4-OHEN±dC 3 H P and 4-OHEN±dA 3 H P were used as standards for analysis of 4-OHEQ-derived DNA adducts.
P-Post-labeling/PAGE analysis
A part of the 32 P-labeled sample was electrophoresed for 4±5 h on a nondenaturing 30% polyacrylamide gel (35 Â 42 Â 0.04 cm) with 1400±1600 V/ 20±40 mA (15) . A 30% polyacrylamide gel was prepared from 40% polyacrylamide solution (60 ml), 10Â TBE buffer, pH 7.0 (10 ml), distilled water (10 ml), 10% ammonium persulfate (0.6 ml) and TEMED (35 ml). 32 P-labeled products was used to determine the radioactivity within the linear range. The relative adduct levels were calculated according to Levay et 32 P-postlabeling analysis, the recovery of 4-OHEN±dC adduct was 50% (S.Shibutani, unpublished data). Therefore, the actual level of 4-OHEN±dC adduct was estimated by dividing the experimental values by 50%. Although the recovery of 4-OHEN±dA has not been determined using the site-specific modified oligomer, the same recovery rate was applied to estimate the level of 4-OHEN±dA adduct.
Results
Level of 4-OHEQ-derived DNA adducts in plasmid vectors
When dN 3 H P was reacted with 4-OHEQ under neutral buffer conditions and labeled with 32 P, 4-OHEQ-modified dA 3 H P , dC 3 H P and dG 3 H P were detected by the 32 P-post-labeling/ PAGE analysis ( Figure 3) . No adducts were detected with dT 3 H P . Using 32 P-post-labeling/PAGE analysis, the level of 4-OHEQ-derived DNA adducts in the plasmid vectors which were reacted with variable amounts (0.02±2.0 mg) of this compound were analyzed. As reported earlier (16), it was observed that 4-OHEQ was auto-oxidized to form 4-OHEQ o-quinone, which was isomerized to form 4-OHEN o-quinone. Therefore, 4-OHEQ o-quinone reacts with the DNA, resulting in the identical DNA adducts formed by 4-OHEN o-quinone. As shown in Figure 3 Mutations induced by 4-OHEQ on supF gene 4-OHEQ-treated vector plasmid pMY189 was transfected into the human WI38-VA13 cells and incubated for 3 days to allow replication and mutation fixation. The progeny plasmids were recovered. An indicator E.coli was transformed by the plasmids to determine the plasmid survival and mutation frequency. The number of ampicillin-resistant bacterial colonies was reduced by the increased exposure of 4-OHEQ to the shuttle vectors; in contrast, the proportion of plasmids with the mutated supF gene was increased ( Figure 5 ). When plasmids were treated with 1.8 mM of 4-OHEQ, the mutation frequency (28 Â 10 À4 ) was 12-times higher than that of the control (2.3 Â 10 À4 ). Seventy-eight mutant colonies were obtained from the plasmid treated with 1.8 mM of 4-OHEQ and subjected to sequence analysis. The majority of the 4-OHEQ-induced mutations were base substitutions (78%); the remaining 22% were deletions and insertions (Table I) . Among the base substitutions, 56% showed single base substitutions and 19% showed multiple base substitutions (at least two base substitutions except for the tandem base substitutions). Distribution of the base substitutions observed in the supF gene is shown in Figure 6 . The majority of the 4-OHEQ-induced single base substitutions occurred at the C:G sites (86%). C:G 3 G:C (48%) and C:G 3 A:T (28%) transversions were observed primarily, along with lesser number of C:G 3 T:A transitions (10%) ( Table II) . Small number of A:T 3 T:A transversions (8%) and A:T 3 G:C transitions (8%) were also observed.
Discussion
Mutagenic potential of 4-OHEQ was determined using human fibroblast and pMY189 shuttle vector carrying supF gene C for 1 h with 0.02±2.0 mg of 4-OHEQ in 1.0 ml of 25 mM potassium phosphate buffer, pH 7.4. The recovered DNA (0.1 mg) was digested using nuclease P1 enrichment method and labeled with 32 P, as described in the Materials and methods. 4-OHEQ (2 mg) was also incubated at 37 C for 5 h with 0.5 mg of dA 3 H P , dC 3 H P , dG 3 H P or dT 3 H P in 1.0 ml of 25 mM potassium phosphate buffer, pH 7.4. The dN 3 H P samples (25 mg) was incubated for 1 h with nuclease P1 (1.0 U) in 30 ml of 17 mM sodium succinate buffer (pH 6.0) containing 8 mM CaCl 2 . The reaction mixture was evaporated to dryness and labeled with 32 P. A one-fifth volume of the 32 P-labeled samples was developed for 5 h on a 30% polyacrylamide gel electrophoresis. 4-OHEN±dC 3 H P and 4-OHEN±dA 3 H P were also labeled with 32 P, as described for 4-OHEQ-derived dN 3 H P and used as standards. [g-32 P]ATP (16.7 fmol) was subjected to the gel to quantify DNA adducts derived from 4-OHEQ. (14) . However, when pMY189 plasmid exposed to 4-OHEQ was analyzed using 32 P-postlabeling/PAGE, 4-OHEN± dC adduct was the major adduct, followed by lesser amounts of 4-OHEN±dA adduct (Figures 3 and 4) . Similar observations were seen for the DNA reacted with 4-OHEN (15) . Therefore, mutations detected at C:G pairs in supF gene may have resulted from 4-OHEN±dC adducts.
The mutant frequency was plotted against the number of DNA adducts (4-OHEN±dC plus 4-OHEN±dA) per mutational target sites (Figure 7) . The supF gene consisted of 150 bp nucleotides, but not all the bases are the targets. Literature review revealed that there are 93 target bases in supF gene (24) . From the regression curve of Figure 6 , it was estimated that 38 4-OHEN±dC or 4-OHEN±dA adducts will produce one mutation.
The other possible DNA damages are due to the oxidative adducts induced by 4-OHEQ. 4-OHEQ is autoxidized to an oquinone, which isomerizes to 4-OHEN o-quinone (16) . Reactive oxygen species, which are generated during redox cycling Mutagenic events induced by 4-hydroxyequilin between 4-OHEN o-quinone and their semiquinone radicals, react with cellular DNA, resulting in an increased formation of 8-oxodG and 8-oxodA adducts both in vitro and in vivo (17±21). 8-oxodG has been known to create mutagenic lesions, primarily generating G 3 T transversions in mammalian cells (31±33). 8-oxodG generated in C:G pairs might contribute in part to the C:G 3 A:T mutations observed with 4-OHEQ.
Small numbers of A:T 3 T:A transversions and A:T 3 G:C transitions were also detected at A:T pairs in supF gene. One of the authors (S.S.) has reported that 8-oxodA is relatively a weak mutagenic lesion, generating A 3 C transversions in mammalian cells (33) . Since this mutagenic spectrum was not detected in the present study, contribution of 8-oxodA adduct to mutations generated by 4-OHEQ might be minimal. Mutations observed in A:T pairs might be promoted by 4-OHEN± dA adducts. Therefore, mutations observed in supF gene may be due to the covalent dC and dA adducts and/or 8-oxodG generated by 4-OHEQ.
In conclusion, we have found that 4-OHEQ, a major metabolite of equilin, is mutagenic, generating primary C:G 3 G:C and C:G 3 A:T transversions; sequence dependent mutations were also observed at C:G pairs in Equilin was thought to be a cancer promoter via the activation of the estrogen receptor in the target tissues. However, 4-OHEQ was found to damage DNA and cause mutations, indicating that equilin might act as an initiator of developing breast, ovarian and endometrial cancers.
